Showing results (121-130 of 4,635) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|August 21, 2007
A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancerIan A Cree, Christian M Kurbacher, Alan Lamont, et al.
Anti-Cancer Drugs|August 2, 2007
Targeting Akt in cancer therapyJaclyn LoPiccolo, Courtney A Granville, Joell J Gills, et al.
Anti-Cancer Drugs|August 2, 2007
The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivoElizabeth W Newcomb, Yevgeniy Lukyanov, Tona Schnee, et al.
Anti-Cancer Drugs|August 2, 2007
Induction of apoptosis by sanguinarine in C6 rat glioblastoma cells is associated with the modulation of the Bcl-2 family and activation of caspases through downregulation of extracellular signal-regulated kinase and AktMin Ho Han, Sung Ok Kim, Gi Young Kim, et al.
Anti-Cancer Drugs|December 1, 1991
Taxol: a new and effective anti-cancer drugW J Slichenmyer, D D Von Hoff
Anti-Cancer Drugs|December 1, 1991
Pharmacokinetic behavior of [57Co]bleomycin liposomes in mice: comparison with the unencapsulated substanceI Fichtner, D Arndt, R Reszka, et al.
Anti-Cancer Drugs|February 1, 2007
Reduced expression of Rho guanine nucleotide dissociation inhibitor-alpha modulates the cytotoxic effect of busulfan in HEK293 cellsJanka Reimer, Sandra Bien, Jürgen Sonnemann, et al.
Anti-Cancer Drugs|October 1, 1991
Antitumor effect of 22-oxa-1 alpha,25-dihydroxyvitamin D3, a potent angiogenesis inhibitor, on rat mammary tumors induced by 7,12-dimethylbenz[a]anthraceneT Oikawa, Y Yoshida, M Shimamura, et al.
Anti-Cancer Drugs|April 7, 2007
Induction of apoptosis in human breast adenocarcinoma MCF-7 cells by pterocarnin A from the bark of Pterocarya stenoptera via the Fas-mediated pathwayPo-Lin Kuo, Ya-Ling Hsu, Shu-Chiao Sung, et al.
Anti-Cancer Drugs|April 7, 2007
Role of pegylated liposomal doxorubicin (Caelyx) in the treatment of relapsing ovarian cancerMaría Eva Pérez-López, Teresa Curiel, Jesús García Gómez, et al.
Pageof 464